Côte d'Ivoire vs Madagascar: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Côte d'Ivoire
59.0%
in 2025
Madagascar
56.0%
in 2025
Côte d'Ivoire rank
148th
Madagascar rank
151st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Côte d'Ivoire
- Madagascar
How they compare
Côte d'Ivoire currently reports 59.0% against 56.0% in Madagascar, a difference of 3.0%.
That makes Côte d'Ivoire's figure about 1.1 times Madagascar's.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Madagascar ahead.
Côte d'Ivoire ranks 148th and Madagascar ranks 151st of 194 countries.
Madagascar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 39.1% | 47.6% | 8.5% | Madagascar |
| 2020s | 60.5% | 60.7% | 0.2% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Côte d'Ivoire or Madagascar?
- Côte d'Ivoire, at 59.0% against 56.0% in Madagascar as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Côte d'Ivoire and Madagascar?
- 3.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Madagascar?
- 18 years are reported by both, from 2008 to 2025.
- How do Côte d'Ivoire and Madagascar rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Côte d'Ivoire ranks 148th and Madagascar ranks 151st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.